P3 Health Partners Inc.
NASDAQCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Aric Coffman
- Full Time Employees
- 320
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Address
- 2370 Corporate Circle Henderson NV United States of America 89074
- IPO Date
- Apr 6, 2021
- CIK
- 0001832511
- Website
- p3hp.org
- Similar Companies
- Business
- P3 Health Partners Inc. (NASDAQ: PIII) is a patient-centered, physician-led population health management company that supports primary care providers with value-based care coordination, administrative services, and technology platforms to improve patient outcomes and reduce costs. Founded in 2015 and headquartered in Henderson, Nevada, the company operates clinics and wellness centers across multiple states including Nevada, Arizona, Oregon, Florida, and California, managing approximately 116,000 at-risk Medicare members through partnerships with over 2,700 affiliated primary care providers (PCPs) in 24 counties. P3 offers capitated revenue arrangements under a fully delegated risk model; care management services including personalized plans, care transitions, chronic disease management, and population health analytics; preventive care programs with education, screenings, and lifestyle support; data integration tools from electronic health records (EHR) and predictive analytics; coordinated care teams addressing social determinants of health; and community outreach initiatives such as health fairs and media appearances. In recent developments, P3 formed a strategic partnership with Innovaccer in June 2024 to deploy the Healthcare AI Platform for personalized interventions and cost management; entered a joint venture with Commonwealth Primary Care in December 2025 to expand into new markets and enhance ACO performance; implemented a 1-for-50 reverse stock split in April 2025; provided preliminary 2025 guidance targeting profitability with $1.4-1.45 billion in revenue and execution of $120-170 million in EBITDA expansion initiatives; and reported third quarter 2025 results showing stable medical cost trends, $345 million in revenue, and positive momentum in its Care Enablement Model.
Company News
20/20 Biolabs (NASDAQ:AIDX) and P3 Health Partners (NASDAQ:PIII) Head-To-Head Review
P3 Health Partners Inc. Announces Appointment of Chief Clinical Officer
P3 Health Partners Inc. Announces Appointment of Chief Clinical Officer
Contrasting P3 Health Partners (NASDAQ:PIII) & McKesson (NYSE:MCK)
Analyzing Molina Healthcare (NYSE:MOH) and P3 Health Partners (NASDAQ:PIII)
P3 Health Partners Q2 Earnings Call Highlights
P3 Health Partners Inc. (PIII) Q2 2026 Earnings Call Transcript
P3 Health Partners Announces Second Quarter 2026 Results
P3 Health Partners Schedules Second Quarter 2026 Earnings Release and Conference Call
Trump Rattled Markets Again and These 3 Forgotten Stocks Under $30 Were the Unlikely Winners
P3 Health Partners Announces First Quarter 2026 Results
P3 Health Partners Schedules First Quarter 2026 Earnings Release and Conference Call
P3 Health Partners Inc. (PIII) Q4 2025 Earnings Call Transcript
P3 Health Partners Announces Fourth Quarter and Full Year 2025 Results
P3 Health Partners Schedules Fourth Quarter and Full Year 2025 Earnings Release and Conference Call
P3 Health Partners (NASDAQ:PIII) vs. Tivic Health Systems (NASDAQ:TIVC) Critical Survey
Financial Survey: Mobile-health Network Solutions (NASDAQ:MNDR) vs. P3 Health Partners (NASDAQ:PIII)
KORU Medical Systems (NASDAQ:KRMD) & P3 Health Partners (NASDAQ:PIII) Head to Head Survey
P3 Health Partners (NASDAQ:PIII) & CVR Medical (OTCMKTS:CRRVF) Head to Head Contrast
P3 Expands Footprint Through Joint Venture With Commonwealth Primary Care ACO